Progestogens linked to increased risk of meningioma

News-Medical.Net March 28, 2024, 06:00 AM UTC

Summary: A French study published by The BMJ links prolonged use of certain progestogens to an increased risk of intracranial meningioma. The study, analyzing data from 18,061 women, found a 4.1-fold increased risk with medrogestone, 5.6-fold with medroxyprogesterone acetate, and 2.7-fold with promegestone. Urgent further research is needed to fully understand this risk. The study couldn't establish causation due to its observational nature.

Full article

Article metrics
Significance5.5
Scale7.0
Magnitude7.0
Potential8.0
Novelty6.0
Actionability9.0
Immediacy8.5
Positivity2.0
Credibility8.0

Timeline:

  1. [4.1]
    French study links certain progestogens to meningioma risk (News-Medical.Net)
    39d
    Source
  2. [4.1]
    Progestogen use linked to intracranial meningioma risk in study (News-Medical.Net)
    44d
    Source
  3. [6.0]
    Certain hormone drugs linked to slightly higher brain tumor risk (The Guardian)
    45d